Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Pancreatic Cancer × ADI PEG20 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uveal Melanoma 3 Melanoma 2 Leukemia, Myeloid, Acute 2 Carcinoma, Hepatocellular 2 Sarcoma 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Ichthyosis, X-Linked 1 HER2 Negative Metastatic Breast Cancer 1 Glioma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Advanced Solid Cancers 1 Advanced Pancreatic Cancer 1

Interventions

toripalimab 1 Simvastatin 1 Metformin 1 Digoxin 1 ADI PEG20 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02101580 2020-10-01

Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer

Polaris Group

Phase 1 Completed

Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡